On 1 December 2023, Professor William Hwang, passed the leadership baton to Professor Lim Soon Thye.
Prof Lim Soon Thye is CEO, NCCS, and Deputy Group CEO (Research & Education), SingHealth, with effect from 1 December 2023
Prof Lim Soon Thye is an esteemed clinician leader responsible for overseeing clinical strategy, and professional and clinical quality at NCCS in his former role as Deputy CEO (Clinical), NCCS. He developed novel models of care and established new clinical services to meet patient-needs, such as geriatric oncology, cancer genetics and molecular tumour boards. He also headed the development of integrated cancer service lines bringing together all cancer service providers across SingHealth's institutions to ensure seamless delivery of cancer care across the cluster. He was also instrumental in supporting the move to the new NCCS building and ensuring the smooth transition of clinical services.
An internationally renowned key opinion leader with an exemplary clinical and research track record in the field of lymphoma, Prof Lim holds many clinical and research leadership roles. He is the recipient of the Tanoto Foundation Professorship in Medical Oncology, is a national clinician scientist, and is involved in multiple wide-ranging collaborations with local and international institutions, that have led to successful research and academic endeavours.
In his new role as CEO of NCCS, Prof Lim will build on the strong foundations laid and further advance clinical and academic excellence in oncology. Prof Lim's new appointment will run concurrently with his role as Deputy Group CEO (Research & Education), SingHealth.
Prof William Hwang was conferred the title of Senior Advisor, SingHealth on 1 December 2023
Throughout his six-year tenure, Prof Hwang led the planning and delivery of key infrastructure, service and operations projects, and new patient care and research initiatives to improve care and clinical outcomes for cancer patients. During the pandemic, he galvanised NCCS to deliver timely cancer care while ensuring that patients and staff were kept safe and well-supported. He oversaw the planning and development of the new NCCS building and steered the Centre's successful move to its new home in late 2022. On 1 December 2023, Prof Hwang was conferred the title of Senior Advisor, SingHealth, to the SingHealth Board of Advisors; and continues to serve as Co-Director of the Regenerative Medicine Institute of Singapore (REMEDIS), and Senior Consultant in the Department of Haematology, Singapore General Hospital and NCCS.
Subscribe to our mailing list to get the updates to your email inbox...
